Literature DB >> 22364871

Cellular functions of tissue transglutaminase.

Maria V Nurminskaya1, Alexey M Belkin.   

Abstract

Transglutaminase 2 (TG2 or tissue transglutaminase) is a highly complex multifunctional protein that acts as transglutaminase, GTPase/ATPase, protein disulfide isomerase, and protein kinase. Moreover, TG2 has many well-documented nonenzymatic functions that are based on its noncovalent interactions with multiple cellular proteins. A vast array of biochemical activities of TG2 accounts for its involvement in a variety of cellular processes, including adhesion, migration, growth, survival, apoptosis, differentiation, and extracellular matrix organization. In turn, the impact of TG2 on these processes implicates this protein in various physiological responses and pathological states, contributing to wound healing, inflammation, autoimmunity, neurodegeneration, vascular remodeling, tumor growth and metastasis, and tissue fibrosis. TG2 is ubiquitously expressed and is particularly abundant in endothelial cells, fibroblasts, osteoblasts, monocytes/macrophages, and smooth muscle cells. The protein is localized in multiple cellular compartments, including the nucleus, cytosol, mitochondria, endolysosomes, plasma membrane, and cell surface and extracellular matrix, where Ca(2+), nucleotides, nitric oxide, reactive oxygen species, membrane lipids, and distinct protein-protein interactions in the local microenvironment jointly regulate its activities. In this review, we discuss the complex biochemical activities and molecular interactions of TG2 in the context of diverse subcellular compartments and evaluate its wide ranging and cell type-specific biological functions and their regulation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364871      PMCID: PMC3746560          DOI: 10.1016/B978-0-12-394305-7.00001-X

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  406 in total

Review 1.  Apoptosis.

Authors:  L Fesus
Journal:  Immunol Today       Date:  1992-08

2.  Transglutaminase activity in primary and subcultured rat astroglial cells.

Authors:  A Campisi; M Renis; A Russo; V Sorrenti; C Di Giacomo; C Castorina; A Vanella
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

Review 3.  Structure-function relationships of transglutaminases--a contemporary view.

Authors:  Zoltán Nemes; Goran Petrovski; Eva Csosz; László Fésüs
Journal:  Prog Exp Tumor Res       Date:  2005

4.  Tissue transglutaminase: from biological glue to cell survival cues.

Authors:  Kapil Mehta; Jansina Y Fok; Lingegowda S Mangala
Journal:  Front Biosci       Date:  2006-01-01

5.  "Activation of tissue tranglutsaminase by removal of carboxyl-terminal peptides".

Authors:  Bassam M Fraij
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

6.  Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells.

Authors:  Evgeny A Zemskov; Irina Mikhailenko; Elizabeth P Smith; Alexey M Belkin
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

7.  Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Authors:  Anna Janiak; Evgeny A Zemskov; Alexey M Belkin
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

Review 8.  Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.

Authors:  Carla Esposito; Ivana Caputo
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

9.  Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.

Authors:  Amit Verma; Sushovan Guha; Huamin Wang; Jansina Y Fok; Dimpy Koul; James Abbruzzese; Kapil Mehta
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

10.  Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes.

Authors:  M D George; T M Vollberg; E E Floyd; J P Stein; A M Jetten
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

View more
  86 in total

1.  Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.

Authors:  S Deasey; D Nurminsky; S Shanmugasundaram; F Lima; M Nurminskaya
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

2.  Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.

Authors:  Laura Yunes-Medina; Julianne Feola; Gail V W Johnson
Journal:  Neuroreport       Date:  2017-12-13       Impact factor: 1.837

3.  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Zachary Herrera; Megan Albertelli; Chaitan Khosla
Journal:  J Med Chem       Date:  2014-10-31       Impact factor: 7.446

4.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

Review 5.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

Review 6.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 7.  Mechanisms of the inward remodeling process in resistance vessels: is the actin cytoskeleton involved?

Authors:  Jorge A Castorena-Gonzalez; Marius C Staiculescu; Christopher Foote; Luis A Martinez-Lemus
Journal:  Microcirculation       Date:  2014-04       Impact factor: 2.628

Review 8.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

9.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

10.  Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.

Authors:  Ji Zhang; Yi-Rong Ding; Rui Wang
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.